These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7094416)

  • 1. Pharmacokinetics of digoxin in C.A.P.D.
    De Paepe M; Belpaire F; Bogaerts Y
    Clin Exp Dial Apheresis; 1982; 6(1):65-73. PubMed ID: 7094416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of hemodialysis on digoxin pharmacokinetics in heart failure in patients with chronic kidney failure].
    Kholodov LE; Glezer MG; Grigor'eva EA; Ksenzenko BL; Solianik GI
    Kardiologiia; 1984 Jun; 24(6):94-7. PubMed ID: 6748501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinidine pharmacokinetics in continuous ambulatory peritoneal dialysis.
    Chin TW; Pancorbo S; Comty C
    Clin Exp Dial Apheresis; 1981; 5(4):391-7. PubMed ID: 7341025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
    Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
    Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis.
    Albin H; Ragnaud JM; Demotes-Mainard F; Vinçon G; Couzineau M; Wone C
    Eur J Clin Pharmacol; 1986; 31(4):479-83. PubMed ID: 3816928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of teicoplanin in patients on continuous ambulatory peritoneal dialysis.
    Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G; Bonati M
    Eur J Clin Pharmacol; 1986; 31(4):501-4. PubMed ID: 2949981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atenolol pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.
    Salahudeen AK; Wilkinson R; McAinsh J; Bateman DN
    Br J Clin Pharmacol; 1984 Sep; 18(3):457-60. PubMed ID: 6487486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic aspects of digoxin in patients with terminal renal failure. II. On hemodialysis.
    van der Vijgh WJ
    Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):255-9. PubMed ID: 881277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic studies of cefoxitin in continuous ambulatory peritoneal dialysis.
    Arvidsson A; Alván G; Tranaeus A; Malmborg AS
    Eur J Clin Pharmacol; 1985; 28(3):333-7. PubMed ID: 4007038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of digoxin during maintenance haemodialysis.
    Iisalo E; Forsström J
    Ann Clin Res; 1974 Aug; 6(4):203-6. PubMed ID: 4429332
    [No Abstract]   [Full Text] [Related]  

  • 11. Myoglobin elimination in end stage kidney disease patients on renal replacement treatment.
    Stefanović V; Bogićević M; Mitić M
    Int J Artif Organs; 1993 Sep; 16(9):659-61. PubMed ID: 8294158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpretation of serum digoxin values in renal failure.
    Gault H; Vasdev S; Vlasses P; Longerich L; Dawe M
    Clin Pharmacol Ther; 1986 May; 39(5):530-6. PubMed ID: 3698461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin-quinidine interaction in patients with chronic renal failure.
    Fenster PE; Hager WD; Perrier D; Powell JR; Graves PE; Michael UF
    Circulation; 1982 Dec; 66(6):1277-80. PubMed ID: 7139903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis patients.
    Vychytil A; Födinger M; Papagiannopoulos M; Wölfl G; Hörl WH; Sunder-Plassmann G
    Kidney Int; 1999 May; 55(5):2054-61. PubMed ID: 10231471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intermittent peritoneal dialysis and continuous ambulatory peritoneal dialysis].
    Radovanović Lj; Popović J; Radlović O
    Srp Arh Celok Lek; 1988; 116(11-12):967-76. PubMed ID: 3247614
    [No Abstract]   [Full Text] [Related]  

  • 16. Paracetamol and its metabolites in saliva and plasma in chronic dialysis patients.
    Lee HS; Ti TY; Lye WC; Khoo YM; Tan CC
    Br J Clin Pharmacol; 1996 Jan; 41(1):41-7. PubMed ID: 8824692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical pharmacokinetics of furosemide during continuous ambulatory peritoneal dialysis].
    Boutron H; Singlas E; Brocard JF; Charpentier B; Fries D
    Therapie; 1985; 40(3):155-9. PubMed ID: 4012661
    [No Abstract]   [Full Text] [Related]  

  • 18. Minerals, vitamin D, and parathyroid hormone in continuous ambulatory peritoneal dialysis.
    Delmez JA; Slatopolsky E; Martin KJ; Gearing BN; Harter HR
    Kidney Int; 1982 Jun; 21(6):862-7. PubMed ID: 6897087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.
    Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E
    Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin removal from a patient with renal failure by hemoperfusion with Amberlite XAD-4 resin.
    Hoy W; Gibson TP; Biddle T
    Artif Organs; 1979 May; 3(2):124-6. PubMed ID: 533394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.